Bristol-Myers Squibb Company
🇺🇸United States
Clinical Trials
79
Active:11
Completed:45
Trial Phases
3 Phases
Phase 1:7
Phase 3:2
Not Applicable:62
Drug Approvals
3
NMPA:3
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (71 trials with phase data)• Click on a phase to view related trials
Not Applicable
62 (87.3%)Phase 1
7 (9.9%)Phase 3
2 (2.8%)No trials found
News
Real-World Data Confirms Mavacamten's Safety and Efficacy in Hypertrophic Cardiomyopathy Treatment
Data from over 5,500 patients in the REMS program showed a low incidence of ejection fraction drop (4.6%) and heart failure hospitalization (1%).